what is a typical maintenance dose of tirzepatide Dosing Chart 2026: 2.5-15 mg Titration & Units Microdosing Tirzepatide Chart - Gift

But vigilance remains important, both at the start of treatment and throughout your time with any provider

Tirzepatide has emerged as one of the most effective GLP-1 receptor agonists for weight management, with clinical trials showing average weight loss of 15-22% of baseline body weight over 68 weeks

The 28-day window begins on the date your shipment arrives, not the compounding date, since PlexusDx coordinates logistics to minimize time in transit

GLP-1 agonists can decrease absorption of birth control pills, which may lead to unplanned pregnancy

Most people continue losing weight steadily for a little over a year (16.5 months), with the most noticeable weight loss happening in the first 89 months